Headlands Technologies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,629
Closed -$575K 816
2025
Q4
$575K Buy
+5,629
New +$504K 0.05% 377
2024
Q3
Sell
-11,760
Closed -$340K 1312
2024
Q2
$340K Buy
+11,760
New +$274K 0.04% 359
2024
Q1
Sell
-2,353
Closed -$63.6K 1357
2023
Q4
$63.6K Buy
2,353
+1,844
+362% +$48.4K 0.02% 484
2023
Q3
$15.1K Buy
+509
New +$17.9K 0.01% 642

Other funds holding GH

Headlands Technologies's GH Position: Q1 2026 in Review

Headlands Technologies sold out of Guardant Health (GH) in Q1 2026, closing a stake of 5,629 shares — an estimated $575K sold.

Headlands Technologies first reported a position in GH in Q3 2023 and held it in 4 quarters. The position peaked at $575K in Q4 2025. 486 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Headlands Technologies reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 5,629 Guardant Health shares in Q1 2026, an estimated $575K.
  • Headlands Technologies first reported a position in Guardant Health in Q3 2023 and held it in 4 quarters.
  • Headlands Technologies's Guardant Health position peaked at $575K in Q4 2025.
  • 486 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.